FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse - FDA Press Releases

FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse

from Food and Drug Administration--Press Releases https://ift.tt/2GS9kRv
via IFTTT